Venture Life Group (LON:VLG) Posts Quarterly Earnings Results

Venture Life Group (LON:VLG) issued its earnings results on Tuesday. The company reported GBX 4.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Venture Life Group had a net margin of 17.42% and a return on equity of 7.82%.

Venture Life Group Price Performance

Venture Life Group stock opened at GBX 65.30 on Wednesday. The stock has a market cap of £78.39 million, a price-to-earnings ratio of 14.94, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.71 and a quick ratio of 1.48. Venture Life Group has a 1 year low of GBX 52 and a 1 year high of GBX 72. The firm has a 50-day moving average of GBX 67.48 and a two-hundred day moving average of GBX 65.11.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.